Abstract
INTRODUCTION
Preeclampsia is a hypertensive disorder in pregnancy, a multiple organ dysfunction of pregnant women during the second and third trimesters of pregnancy. It is characterized by hypertension, proteinuria and edema 20 weeks into pregnancy. The incidence of stroke in China is 9.4 %, while in foreign countries it ranges from 7 to 12 % [1] . Preeclampsia is a major contributory factor to pre-natal morbidity and mortality [2, 3] .
The pathogenesis of preeclampsia has been attributed to different factors. Studies on preeclampsia within and outside China have tended to focus on factors such as genetic susceptibility, immune mal-adaptation, placental ischemia and oxidative stress [4] . One of the most popular hypotheses posits a relationship between the pathogenesis of preeclampsia and abnormal immune tolerance [5, 6] . Some scholars believe that the embryo carries paternal gene. Thus the embryo is homologous graft for mother, resulting in an immune reaction between embryo and mother [7] . Other researchers are of the view that immune tolerance can protect the embryo as a homologous graft from rejection by the maternal immune system [3, 8] . In early pregnancy, trophoblast cells may invade the myometrium and spiral artery without being identified and excluded by the maternal immune system. This is associated with MHC expressed in trophoblast cells. Human leukocyte antigen (HLA-G) which belongs to non-classical MHC-I molecules in humans, are highly expressed in maternal-fetal extra-villous cytotrophoblast (EVCT). HLA-G occupies a crucial place in maternal-fetal immune tolerance and the rebuilding of placental vessels [5, 9, 10] .
Polymorphism has been proven in the noncoding and coding regions of HLA-G. The polymorphism in non-coding region of HLA-G includes polymorphism in 3-untranslated region (3-UTR) and 5-upstream regulatory region (5-URR). Much attention has been focused in recent years on the study of 3-UTR polymorphisms.
Research on pregnant women has found a single-nucleotide polymorphism (SNP) in HLA-G 3-UTR involving mutation of normal G in 3172 to A [11] . It is believed that 3172 SNP polymorphism may be associated with preeclampsia, and may be involved in stabilization of HLA-G mRNA. Studies on newborns showed that this polymorphism is associated with severe preeclampsia when the neonatal genotype is SNP 2995 (C) / SNP3127 (G) / SNP3127 (A) / SNP3181 (G) / +14 base pair (bp) homozygote. Irrespective of pregnancy status (i.e. normal pregnancy or preeclampsia), the results were attributed to mother-baby gene interaction. Thus it would not be comprehensive enough to limit pathogenesis of preeclampsia to mother or embryo; a more comprehensive study of the pathogenesis must focus on compatible genotype of both sides by analyzing mother-baby gene interaction. This is due to the fact that interaction between mother and embryo may influence the status of pregnancy. The present study was aimed at a more comprehensive approach to the pathogenesis of preeclampsia from the relationship between HLA-G polymorphism and preeclampsia based on genotype compatibility between mother and embryo.
METHODS

Study subjects
From October 2008 to November 2010, pregnant women with single embryo, who were attended to in the Department of Obstetrics and Gynecology at the Third Affiliated Hospital of Zhengzhou University, China, were selected for the study. These women were randomly divided into two groups: preeclampsia group (case group) and normal pregnancy group (control group).There were 144 cases of pregnant women and their newborns in the preeclampsia group. The mean age of the pregnant women was 31.40 ± 1.76years, and the mean gestational period was 34.85 ± 5.14 weeks. In the normal pregnancy group, there were 122 cases of pregnant women and their newborns. The mean age of the pregnant women was 31.39 ± 4.2 years, while the mean gestational period was 37.46 ±1.98 weeks. There were significant differences between two groups with respect to age, pregnancy time, gestational period and delivery time (p < 0.05). The pregnant women in both groups were Han residents with no consanguinity and no history of inter-marriage. All of the subjects in the study were monitored for 12 weeks after delivery. Based on the declaration of Helsinki promulgated in 1964 as amended in 1996 [12] , this study was approved by the Ethical Committee of The Third Affiliated Hospital of Zhengzhou University (approval no. 20100312).
Choice of standard
The inclusive criteria of control group were: full term pregnancies, blood pressure lower than 140/90mm Hg and absence of proteinuria. There were no cases of high blood pressure, heart disease, kidney disease, liver disease and diabetes in pregnant women in the two groupss. In addition, they had no history of blood transfusions, immunization, or any complications of pregnancy. All the pregnant women were monitored for 12 weeks after delivery.
DNA extraction
Genomic DNA was extracted from white blood cells obtained from peripheral venous blood (2mL of cord blood of pregnant women and their embryo from the two groups). Extraction of genomic DNA was carried out using a commercial kit.
Expansion of targeted fragments and genetic sequencing
Primers: primer sequence
The primer sequences are shown in Table 1 .
System and reaction conditions
The targeted fragments were amplified by Nested polymerase chain reaction (nPCR. The PCR reaction conditions were: pre-denaturation at 95 o C for 5 min, denaturation at 95°C for 30 s, annealing at 68 °C for 30 s, extended at 72°C for 1 min, a total of 36 cycles, and finally extended at 72°C for 10 min. The PCR products of HLA-G 3-UTR were subjected to 2 % agarose electrophoresis to comply with the requirements of the experimental design (Plate 1).
The first lane is the marker. The second to seventh lanes are 6 aimed genes which were chosen at random (245bp).
Sequencing
Fragments of PCR amplification product 245bp and 3 SNPs were discovered from the resultant sequence. These three different SNPs are located in 3127 site, 3172 site and 3181 site, which lie in HLA-G exon 8 3-UTR. The PCR products were sequenced by reverse sequencing. The tables of sequence obtained were reverse and complementary sequences, which meant that the site in T peak should be interpreted as A, and the site in G peak should be interpreted as C. The tables of sequence from each SNP site in HLA-G gene are shown in Figure 1 .
Statistics
Software SPSS 16.0 was used to analyze all data to determine if the genotypic distribution was in Hardy-Weinberg equilibrium. For analysis of measurement data, t-test was used to compare the two groups. Non-normal distribution measurement data were compared with rank sum test. Differences in genotype distribution were tested by Chi-Square test method of Fourfold table where n ≥ 40 and theoretical frequency (T) ≥ 5; ordinary Chi-Square test was used where n ≥ 40 but 1 ≤ T < 5, corrective ChiSquare test was used; where n < 40 or T < 1, Fisher definite probability method was employed. Testing standard taken was α = 0.05.
RESULTS
Results of analysis of SNP genotype frequency distributions of HLA-G 3-UTR in pregnant women and embryos from the preeclampsia and normal pregnancy groups satisfied the law of HardyWeinberg equilibrium (p > 0.05). Thus the method is suitable for analysis of HLA-G 3-UTR SNP genotype distributions. The study showed that in HLA-G 3-UTR, three single-nucleotide polymorphisms in HLA-G 3-UTR occurred at site 3127 (rs1063320, C→G); site 3172 site (rs9380142, G→A), and site 3181 site (rs1610696, C→G). In HLA-G 3-UTR 3127 site, two alleles G and C, and three genotypes CG, CC and GG existed. The frequency of site G allele in HLA-G 3-UTR 3127 in the preeclampsia group was 47.2 % and the C allele frequency was 52.8 %. G allele frequency in normal pregnancy group was 52.0 %, while the C allele frequency was 48.0 %. There was no significant difference in the C and G allele distribution between the two groups (p > 0.05). HLA-G 3-UTR 3127 site CG genotype frequency in the preeclampsia group was 45.3 %, which was significantly lower than that in the normal pregnancy group (64.7 %, p > 0.05, Table  2 ).
Comparison of embryo HLA-G 3-UTR SNP 3127 genotype and allele frequencies from the two groups
Two alleles were found in HLA-G 3-UTR 3127 site: G and C, as well as 3 genotypes: CG, CC and GG. The frequency distributions of these alleles and genotypes are shown in Table 3 . In the preeclampsia group, G allele frequency was 46.9%, while the C allele frequency was 53.1%. The G allele frequency in normal pregnancy group was 45.1% while the C allele frequency was 54.9%. No significant difference in the two allele frequencies was found between the two groups (χ 2 = 0.044, p = 0.833 > 0.05). In addition, no significant difference in genotype distribution frequencies was found between the two groups (p > 0.05).
Comparison of mother/embryo HLA-G 3-UTR SNP 3127 compatible genotype between the two groups
There was no significant difference in mother/ embryo HLA-G 3-UTR SNP 3127 compatible genotype between the two groups (p > 0.05, Table 4 ). 
Comparison of HLA-G 3-UTR 3172 genotype and allele frequencies
Comparison of HLA-G 3-UTR SNP 3172 genotype and allele frequencies of pregnant women from the two groups
In HLA-G 3-UTR 3172 site, two alleles (G and A), and three genotypes (AG, AA and GG) were present. The G allele frequencies in the preeclampsia and normal pregnancy groups were 42.5 and 36.3%, respectively, while the A allele frequencies in the preeclampsia and normal pregnancy groups were 57.5 and 63.7%, respectively. Between the two groups, no significant differences were found (χ 2 = 0.831, p = 0.362 > 0.05). The frequency of AA genotype in the preeclampsia group (50.9%) was significantly higher than that in the normal pregnancy group (25.5%, p < 0.05; Table 5 ).
Comparison of HLA-G 3-UTR SNP 3172 genotype and allele frequencies of embryo from the two groups
In HLA-G 3-UTR 3172 site, two alleles: G and A; and three genotypes: AG, AA and GG were present. The frequencies of G allele in the preeclampsia and normal pregnancy groups were 45.3 and 43.9%, respectively. The frequencies of the A allele in the preeclampsia and normal pregnancy groups were 54.7 and 56.1%, respectively. There were no significant differences in allele frequencies between the two groups (p > 0.05). Moreover, there were no significant differences in genotype distribution frequencies between the two groups (p > 0.05, Table 6 ).
Comparison of mother/ embryo HLA-G 3-UTR SNP 3172 compatible genotype between the two groups
The frequency of compatible AA/AA genotype frequency of mother/ embryo HLA-G 3-UTR 3172 site in the preeclampsia group (55.6%) was significantly higher (p < 0.05) than that in the normal pregnancy group (28.6%, Table 7 ).
Comparison of HLA-G 3-UTR SNP 3181 genotype and allele frequencies
Comparison of HLA-G 3-UTR SNP 3181 Genotype and allele frequencies of pregnant women from the two groups
There were 2 alleles (G & C) and 3 genotypes (CG, CC & GG) in HLA-G 3-UTR 3181 site. No significant difference in G allele frequencies was found between the preeclampsia group (33.0%) and the normal pregnancy group (36.3%, p > 0.05). Similarly, there was no significant difference in C allele frequency between the normal pregnancy group (63.7%) and the C allele frequency in the preeclampsia group (67.0%, p > 0.05; Table 8 ).
Comparison of HLA-G 3-UTR SNP 3181 genotype and allele frequencies in embryos from the two groups
The G allele frequencies in embryos in the preeclampsia and normal pregnancy groups were 20.7 and 34.1%, respectively, while the corresponding frequencies of the C allele were 57.3 and 65.9 %, respectively (p > 0.05; Table  9 ). The frequency of compatible CC/GG genotype in mother/embryo HLA-G 3-UTR 3181 site in the preeclampsia group (14.8%) was significantly lower than that in normal pregnancy group (40.0%) (p < 0.05; Table 10 ).
DISCUSSION
In this study, 3 SNPs were discovered in HLA-G exon 8 3-UTR. The three different SNPs were located in 3127 site (rs1063320), 3172 site (rs9380142) and 3181 site (rs1610696).
This study has demonstrated that the frequency of SNP 3127 site CG genotype in pregnant women with preeclampsia (45.3 %) was significantly lower than that in normal pregnancy group (64.7 %). However there was no significant difference in compatible genotype distributions between the two groups. Consequently, it can be concluded that women with CG genotype in HLA-G 3-UTR SNP 3127 site have lower risk of preeclampsia. There was no difference in SNP 3127 genotype frequency distributions in newborn between the two groups. This is contrary to the results of Larsen, who reported significant differences in CG genotype distributions between Caucasian preeclampsia and normal pregnancy groups [13] . This difference might be due to the differences in ethnic groups and geographic regions.
The significant difference in AA genotype frequencies between the preeclampsia and normal pregnancy groups is in agreement with the findings of Yie [12] . Since pregnancy is a special physiological state, these results, whether in preeclampsia or normal pregnancy, are most likely due to mother-baby gene interaction. In effect, the pathogenic gene could be from mother or from the embryo. Consequently, combination analysis of compatible genotype between mother and embryo may provide insight into the pathogenesis of preeclampsia. In this study, it was found from analysis of mother/ embryo compatible genotype that the frequencies of mother/ embryo compatible AA/ AA genotype in the preeclampsia group was higher than the frequency in normal pregnancy group. This strongly suggests that HLA-G 3-UTR SNP 3172 may be a pre-disposing gene for preeclampsia, and may increase risk of preeclampsia. However, there were no significant differences in genetic polymorphisms between newborns in the two groups. This is consistent with the results of Larsen [12] . In Caucasian newborn the A allele occurs primarily in normal pregnancy rather than in preeclampsia. Moreover there was no significant difference in HLA-G 3-UTR 3172 genotype between the two groups.
It is believed that HLA-G 3172 site is near to an AUUA motif [12] . The AU motif is a sequence which consists of uridylic acid and some adenosine, a kind of cis-acting degradation signal which can encode cytokines, growth factors and other regulating proteins. It also influences the stability of 3-UTR mRNAs [14, 15] . It has been established that A allele can reduce the stability of HLA-G mRNAs [12] . Therefore mutation in this site reduces the level of mRNA and then causes changes in transcription and translation, leading to decreased HLA-G protein expression. This reduces maternal-fetal immune tolerance, and also reduces physical protective reaction between mother and baby. In addition, it decreases the invasive ability of trophoblast cells. Superficial implantation of placenta causes ischemia and placental hypoxia. The results of this research show no significant difference in HLA-G SNP 3182 polymorphisms between mother and embryo in the two groups. This finding agrees with that of Larsen [13] . In Caucasian newborn, the frequency of CG/ CG genotype in mother/ embryo 3181 site in the preeclampsia group was lower than that in the normal pregnancy group. This implies that populations with mother/embryo compatible genotype (CG/CG) in HLA-G 3181 site have lower risk of preeclampsia.
However some researchers believe that there is complete linkage disequilibrium between HLA-G 14bp allele and the three SNPs (SNP 2995, SNP 3127 and SNP 3172). SNP 3172 and SNP 3181 are on the right side of AU-motif which is associated with the stability of mRNA. When 14bp deletion polymorphism is combined with SNP 3127, it is linked to primipara with severe preeclampsia. Research has shown that HLA-G 14bp deletion polymorphism is a special genotype of exon 8. When embryo genotype is SNP2995 (C) / SNP3127 (G) / SNP3172 (A) / SNP3181 (G) / +14bp homozygotes, it is associated with primipara with severe preeclampsia. Therefore it is important to study the relationship between HLA-G 3-UTR polymorphism and preeclampsia from linkage dis-equilibrium, analyze the impact of SNP polymorphism near to AU-motif on the stability of mRNA, and the impact of the HLA-G protein expression in the placenta.
CONCLUSION
This study has demonstrated that there might be a relationship between HLA-G 3-UTR SNP 3172 polymorphism and susceptibility to preeclampsia in China Henan Han population. It has shown that preeclampsia is a disease of abnormal immune tolerance between mother and embryo, and provided new empirical evidence for pathogenesis of the disease. The results also provide an important clue for predicting likelihood of preeclampsia, as well as prospects for gene therapy by analyzing differences in compatible genotype between mother and embryo.
